Actimmune (interferon gamma-1b) — United Healthcare
Chronic Granulomatous Disease (CGD)
Initial criteria
- Diagnosis of chronic granulomatous disease
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Actimmune
Approval duration
12 months